[1] [7] Additionally, because glucagon promotes glycogenolysis and gluconeogenesis, there is a theoretical concern regarding glucose management in people with type 2 diabetes, although the GLP-1 and GIP components appear to counterbalance this effect in practice
Copper GHK is an oral liposomal copper tripeptide complex, GHK-Cu, designed tohelpreplenish endogenous GHK-Cu to more youthful levels
N-acetylcysteine Pharmacology and Applications in Rare DiseasesRepurposing an Old Antioxidant
Aanbevolen dosering niet overschrijden
Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension
In our work, we compared the incidence of cardiovascular events and all-cause mortality between persistent and non-persistent GLP-1RA users